You just read:

Innocoll Announces Top-line Results from its Phase 2 Clinical Trial Investigating XaraColl® for the Management of Post-operative Pain and Receives "Notice of Allowability" for XaraColl U.S. Patent Application

News provided by

Innocoll, Inc.

Sep 13, 2011, 07:00 ET